Advertisement
Zetia Coupon - Zetia 10mg tablet

Ezetimibe

Ezetimibe (Zetia) is an expensive drug used to lower blood cholesterol for patients who are at risk of getting heart disease or a stroke. It is only for patients whose cholesterol level is not controlled by diet. This drug is more popular than comparable drugs. It is available in generic and brand versions. Generic ezetimibe is covered by most Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower. The lowest GoodRx price for the most common version of ezetimibe is around $13.52, 93% off the average retail price of $199.67. Compare cholesterol absorption inhibitors.
Zetia Coupon - Zetia 10mg tablet

Zetia Latest News

Get the latest updates on this drug from the GoodRx medical team

80+ Drugs to Be Dropped By Insurance in 2018

Elizabeth Davis - August 22, 2017

If you’ve got health insurance, now’s a good time to be paying attention. Each year, prescription coverage – the “formulary” – changes, and yours will likely be changing in 2018.

Express Scripts and Caremark, companies that handle pharmacy benefits for more than 200 million Americans, are removing more than 80 prescription medications from their formularies at the end of 2017. See More

Generic Zetia for High Cholesterol Now Available

Roni Shye - January 10, 2017

For some people, high cholesterol can be passed down through the family, and for others, diet can cause higher than normal cholesterol levels.

Whatever the reason, we have some good news for those of you taking the expensive cholesterol medication Zetia! As of December 12th, 2016 the FDA approved ezetimibe, a less expensive generic to Zetia, and it is in pharmacies now.

What is Zetia (ezetimibe) indicated for?

Zetia (ezetimibe) is prescribed in combination with a proper diet for the treatment of high cholesterol. See More

What’s the Deal With Zetia (Ezetimibe): A Good Alternative to Statins for Preventing Heart Attack and Stroke?

Dr. Sharon Orrange - November 25, 2014

When I read criticisms of doctors prescribing expensive medications that might not benefit patients at all, I think of Zetia (ezetimibe) as the poster child. News came out last week after the IMPROVE-IT trial that seemed to pump it up, but what we learned from this large trial may surprise you and let you down at the same time.

  1. Billions and billions of dollars have already been spent on Zetia—despite not knowing whether it has any benefit to you other than lowering LDL cholesterol a little bit.
  2.  See More

RIP Non-Statin Cholesterol Meds

Dr. Sharon Orrange - November 19, 2013

Guidelines change the way we practice medicine. This is a good thing because sweeping guidelines are based on interpretations of years of good strong studies. The new cholesterol guidelines place the burden of lowering LDL cholesterol on statin drugs because they work.

Lowering LDL cholesterol is now not just about chasing a number (70, 100, 130) but about lowering yours by 25-50% if you meet the indications for treatment. See More

Hear Ye Hear Ye! Are the New Cholesterol Recommendations the Game-Changer of 2013?

Dr. Sharon Orrange - November 15, 2013

For the first time in a decade, the American College of Cardiology (ACC) and the American Heart Association (AHA) have made new recommendations for who we treat with statins for high cholesterol and toward what goal. The new guidelines are different. Here is what you need to know:

 •  Gone are the recommended LDL cholesterol targets, specifically those that ask physicians to treat patients with cardiovascular disease to less than 100 or the optional goal of less than 70. See More

Meet Liptruzet! A New Combination Cholesterol Drug

Dr. Sharon Orrange - June 14, 2013

Liptruzet is a new player in the cholesterol lowering game making an appearance as the second combination of Zetia (ezetimibe) and a statin drug—in this case, atorvastatin (Lipitor). Liptruzet is the combination of the active ingredient of Zetia called ezetimibe (not a statin) mixed with the well known statin atorvastatin, and will be used to lower LDL cholesterol. Vytorin, a combination of ezetimibe and simvastatin, was released in 2004. See More

Finally, a Non-Statin Cholesterol Medication That Works: Introducing Juxtapid

Dr. Sharon Orrange - January 30, 2013

Aside from Zetia there haven’t been any good non-statin options for lowering LDL Cholesterol. Statin drugs like Lipitor (atorvastatin), Zocor (simvastatin) and Crestor work well to lower the “bad” cholesterol, the LDL, and have remained first line therapy for many years. Finally, there may be something new to get excited about. But, it does have some “issues.”

Juxtapid is a new medication approved for lowering cholesterol. See More

Top 10 Questions About Cholesterol Medications, aka The Statins

Dr. Sharon Orrange - January 20, 2012

Whether you take atorvastatin (Lipitor), simvastatin (Zocor), or Crestor (rosuvastatin), most statin medications—used for lowering cholesterol—have a very similar risk and benefit profile.

Almost one in four Americans now take a statin, so many of you may have questions about a new or existing prescription. Here are the answers to the most common questions I am asked about statin drugs by my patients:

  1. Will they hurt my liver? Out of the ordinary liver tests are only seen in fewer than 1 in 100 patients taking statin drugs, and this will go away if you stop the medication.
  2.  See More
GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.
In all states except Tennessee, GoodRx is considered a marketer of prescription discount cards, and is not required to register as a discount card provider. In Tennessee, GoodRx is registered as a Prescription Drug Discount Plan Operator.
Safe Pharmacy